Activation of the glucocorticoid receptor with overproduction of active cortisol is thought to result in multiple clinical characteristics of the metabolic syndrome including insulin resistant type 2 diabetes mellitus (T2DM), visceral obesity, dyslipidemia and arterial hypertension [1]. The gene discussed is NR3C1; the disease is metabolic syndrome.